<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05044910</url>
  </required_header>
  <id_info>
    <org_study_id>2019037</org_study_id>
    <nct_id>NCT05044910</nct_id>
  </id_info>
  <brief_title>The Impact of Malnutrition on Immune Responses to Tuberculosis</brief_title>
  <acronym>TBMAM</acronym>
  <official_title>The Impact of Malnutrition on Immune Responses to Tuberculosis in Indian Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tuberculosis Research Centre, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Child Health, Madras Medical College, Chennai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanley Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kanchi Kamakoti Childs Trust Hospital, Chennai, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tuberculosis Research Centre, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess immune responses to Mtb in children with MAM compared to&#xD;
      well-nourished children and to evaluate the impact of a nutrition intervention on these&#xD;
      immune responses.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Immune dysfunction in malnourished children is poorly characterised. The aim of this study is&#xD;
      to assess immune responses to Mycobacterium tuberculosis (Mtb) in children with moderate&#xD;
      acute malnutrition (MAM) compared to wellnourished children and to evaluate the impact of a&#xD;
      nutrition intervention on these immune responses. Innate and adaptive immune responses to Mtb&#xD;
      will be characterised in four groups: 1) MAM children with TB disease; 2) Wellnourished&#xD;
      children with TB disease; 3) MAM children with latent TB infection; 4) Well-nourished&#xD;
      children with latent TB infection. A range of assays to compare innate, adaptive and&#xD;
      functional immune responses to TB between groups will be performed. Whether nutritional&#xD;
      supplementation improves immune function in MAM children remains uncertain. Hence, children&#xD;
      in all four groups will be followed up during 6 months of TB therapy/chemoprophylaxis. MAM&#xD;
      children will receive 12 weeks of concomitant ready-to-use supplementary food, to evaluate&#xD;
      longitudinal changes in innate and adaptive immune function, monocyte:lymphocyte ratio and&#xD;
      mycobacterial growth inhibition. The results of this study will provide data to understand&#xD;
      the reasons for infection susceptibility in malnourished children and provide a&#xD;
      proof-of-concept that nutritional rehabilitation promotes immune rehabilitation. It will also&#xD;
      provide a proof-of concept for use of nutritional supplementation as adjust therapy in TB&#xD;
      disease&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IFNγ concentration</measure>
    <time_frame>6 months</time_frame>
    <description>IFNγ concentration in supernatant after overnight incubation of whole blood with TB antigens</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Malnutrition, Child</condition>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>MAM children with TB disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Wellnourished children with TB disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>MAM children with latent TB infection</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Well-nourished children with latent TB infection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ready to Use supplementary food (RUSF)</intervention_name>
    <description>Children with malnutrition will be given RUSF</description>
    <arm_group_label>MAM children with TB disease</arm_group_label>
    <arm_group_label>MAM children with latent TB infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HIV negative, BCG vaccinated&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12-60 months&#xD;
&#xD;
          -  HIV-negative&#xD;
&#xD;
          -  BCG vaccinated&#xD;
&#xD;
          -  Moderate acute malnutrition (WHZ -2 to -3 or MUAC 115 - 125mm ± HAZ &lt;-2)&#xD;
&#xD;
          -  TB disease&#xD;
&#xD;
          -  Latent TB infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria not met&#xD;
&#xD;
          -  Severe acute malnutrition (WHZ&lt;-3; MUAC&lt;115mm; bilateral oedema)&#xD;
&#xD;
          -  Severe anaemia (Hb: &lt;7g/dl)&#xD;
&#xD;
          -  Chronic infection (HIV, hepatitis B or C)&#xD;
&#xD;
          -  Chronic disease (e.g. Crohn's disease)&#xD;
&#xD;
          -  Feeding problems (eg cerebral palsy) that prevent ingestion of RUSF&#xD;
&#xD;
          -  Known nut allergy&#xD;
&#xD;
          -  MDR TB disease and contacts of MDR TB adults&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>60 Months</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Aishwarya Venkataraman, MRCPCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>ICMR-NIRT</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aishwarya Venkataraman, MRCPCH</last_name>
    <phone>044 2836 9500</phone>
    <phone_ext>9533</phone_ext>
    <email>Aishwarya.v@nirt.res.in</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aishwarya Venkataraman</last_name>
    <phone>044 2836 9500</phone>
    <phone_ext>9533</phone_ext>
    <email>Aishwarya.v@nirt.res.in</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Child Health</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600 008</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarath Balaji</last_name>
      <phone>9443697844</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Government Stanley Medical College and Hospital</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ganesh J</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>malnutrition</keyword>
  <keyword>moderate acute malnutrition</keyword>
  <keyword>immunology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Child Nutrition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be shared according to ICMR rules and regulations after appropriate approvals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

